Advances in graft-versus-host disease biology and therapy

Bruce R. Blazar, William J. Murphy, Mehrdad Abedi

Research output: Contribution to journalReview article

489 Scopus citations

Abstract

Allogeneic haematopoietic stem cell transplantation is used to treat a variety of disorders, but its efficacy is limited by the occurrence of graft-versus-host disease (GVHD). The past decade has brought impressive advances in our understanding of the role of stimulatory and suppressive elements of the adaptive and innate immune systems from both the donor and the host in GVHD pathogenesis. New insights from basic immunology, preclinical models and clinical studies have led to novel approaches for prevention and treatment. This Review highlights the recent advances in understanding the pathophysiology of GVHD and its treatment, with a focus on manipulations of the immune system that are amenable to clinical application.

Original languageEnglish (US)
Pages (from-to)443-458
Number of pages16
JournalNature Reviews Immunology
Volume12
Issue number6
DOIs
StatePublished - Jun 1 2012

Fingerprint Dive into the research topics of 'Advances in graft-versus-host disease biology and therapy'. Together they form a unique fingerprint.

  • Cite this